The thrombus is a mixture composed of red cells, aggregated platelets, fibrin and other cellular elements, which can cause partial or complete occlusion of a vessel.
STEMart provides thrombosis assay to help manufacturer demonstrate the regulatory compliance of product to blood/device interaction.
Standard of Thrombosis Assay
ISO 10993-4
FDA requirement
STEMart provides thrombosis assay for the medical device including but limited to:
-
External communicating devices in contact with circulating blood
-
Blood monitors
-
Extracorporeal membrane oxygenator system
-
Hemodialysis/hemofiltration equipment
-
Percutaneous circulatory support devices
-
Catheters
-
Guidewires
-
Intravascular endoscopes
-
Intravascular ultrasound
-
Laser systems
-
Retrograde coronary perfusion catheters
-
Implant devices placed largely or entirely within the vascular system
-
Annuloplasty rings
-
Mechanical heart valves
-
Total artificial hearts
-
Ventricular-assist devices
-
Endovascular grafts
-
Implantable defibrillators and cardioverters
-
Pacemaker leads
-
Stents
-
Tissue heart valves
-
Tissue vascular grafts and patches
-
Prosthetic (synthetic) vascular grafts and patches
-
Vena cava filters
-
Intra-aortic balloon pumps
Test Principle of Thrombosis Assay
-
Percentage occlusion
-
Flow reduction
-
Gravimetric analysis
-
Light microscopy
-
Pressure drop across device
-
Scanning electron microscopy
-
Antibody binding
-
Retrieval and examination of device
-
Autopsy of distal organs
-
Imaging techniques
If you have additional questions about Thrombosis Assay or would like to find out more about our services, please feel free to contact us.
Reference
-
International Organization for Standardization. Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood. ISO 10993-4; (2002).